Further studies confirmed that inhibiting NF-κB signaling pathway activity significantly reduced invasion of HCC cells and downregulated the expression of the VEGF and MMP gene families, the latter including MMP-1, MMP-2, MMP-3, and MMP-9 [37, 38]. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.